Nonstructural HIV proteins as targets for prophylactic or therapeutic vaccines
- PMID: 15560981
- DOI: 10.1016/j.copbio.2004.10.008
Nonstructural HIV proteins as targets for prophylactic or therapeutic vaccines
Abstract
By the end of 2004, more than 20 HIV-1 vaccine candidates will have entered clinical testing in at least 30 trials worldwide. Almost half of these vaccines include nonstructural HIV-1 gene products. This represents an important innovation in the HIV vaccine field, because until 9 years ago not even preclinical testing in small animal models had been carried out with such immunogens. This review briefly discusses the experimental evidence that provides the rationale for the use of nonstructural HIV-1 gene products as vaccine antigens, and summarizes the current status and the future development of these novel vaccines.
Similar articles
-
HIV vaccine development: past, present and future.IDrugs. 2010 Dec;13(12):852-6. IDrugs. 2010. PMID: 21154142 Review.
-
Clinical experience with therapeutic AIDS vaccines.Expert Rev Vaccines. 2005 Jun;4(3):289-304. doi: 10.1586/14760584.4.3.289. Expert Rev Vaccines. 2005. PMID: 16026245 Review.
-
Predictive value of primate models for AIDS.AIDS Rev. 2004 Oct-Dec;6(4):187-98. AIDS Rev. 2004. PMID: 15700617 Review.
-
Current strategies and limitations of HIV vaccines.Curr Opin Investig Drugs. 2010 Feb;11(2):192-202. Curr Opin Investig Drugs. 2010. PMID: 20112169 Review.
-
A review of vaccine research and development: the human immunodeficiency virus (HIV).Vaccine. 2006 May 8;24(19):4062-81. doi: 10.1016/j.vaccine.2006.02.031. Epub 2006 Feb 28. Vaccine. 2006. PMID: 16530298 Review.
Cited by
-
A Proteome-Wide Immunoinformatics Tool to Accelerate T-Cell Epitope Discovery and Vaccine Design in the Context of Emerging Infectious Diseases: An Ethnicity-Oriented Approach.Front Immunol. 2021 Feb 26;12:598778. doi: 10.3389/fimmu.2021.598778. eCollection 2021. Front Immunol. 2021. PMID: 33717077 Free PMC article.
-
Preparation and characterization of innovative protein-coated poly(methylmethacrylate) core-shell nanoparticles for vaccine purposes.Pharm Res. 2007 Oct;24(10):1870-82. doi: 10.1007/s11095-007-9310-8. Epub 2007 May 3. Pharm Res. 2007. PMID: 17476465
-
HIV-1 tat promotes integrin-mediated HIV transmission to dendritic cells by binding Env spikes and competes neutralization by anti-HIV antibodies.PLoS One. 2012;7(11):e48781. doi: 10.1371/journal.pone.0048781. Epub 2012 Nov 13. PLoS One. 2012. PMID: 23152803 Free PMC article.
-
Building collaborative networks for HIV/AIDS vaccine development: the AVIP experience.Springer Semin Immunopathol. 2006 Nov;28(3):289-301. doi: 10.1007/s00281-006-0026-3. Epub 2006 Sep 16. Springer Semin Immunopathol. 2006. PMID: 16983452 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical